Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Precision Medicine
Biotech
Boundless boldly goes public with $100M IPO
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024.
James Waldron
Mar 28, 2024 7:10am
Prometheus team returns with brand-new biotech and $400M
Mar 21, 2024 7:00am
Moma’s the word as Roche signs $2B deal to develop cancer drugs
Jan 4, 2024 7:00am
Trio of research companies unite to change liver disease trials
Nov 14, 2023 10:05am
Icon, Saphetor partner on trials targeting precision medicine
Oct 18, 2023 7:05am
Cancer initiative picks Massive Bio for patient trial matching
Jun 7, 2023 3:20pm